IBDEI163 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18764,0)
 ;;=F16.959^^91^960^9
 ;;^UTILITY(U,$J,358.3,18764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18764,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,18764,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,18764,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,18765,0)
 ;;=F16.99^^91^960^17
 ;;^UTILITY(U,$J,358.3,18765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18765,1,3,0)
 ;;=3^Hallucinogen Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,18765,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,18765,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,18766,0)
 ;;=F16.983^^91^960^16
 ;;^UTILITY(U,$J,358.3,18766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18766,1,3,0)
 ;;=3^Hallucinogen Persisting Perception D/O
 ;;^UTILITY(U,$J,358.3,18766,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,18766,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,18767,0)
 ;;=F16.21^^91^960^20
 ;;^UTILITY(U,$J,358.3,18767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18767,1,3,0)
 ;;=3^Hallucinogen Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,18767,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,18767,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,18768,0)
 ;;=F16.11^^91^960^18
 ;;^UTILITY(U,$J,358.3,18768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18768,1,3,0)
 ;;=3^Hallucinogen Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,18768,1,4,0)
 ;;=4^F16.11
 ;;^UTILITY(U,$J,358.3,18768,2)
 ;;=^268239
 ;;^UTILITY(U,$J,358.3,18769,0)
 ;;=F11.10^^91^961^25
 ;;^UTILITY(U,$J,358.3,18769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18769,1,3,0)
 ;;=3^Opioid Use DO,Mild,Uncomp
 ;;^UTILITY(U,$J,358.3,18769,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,18769,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,18770,0)
 ;;=F11.129^^91^961^22
 ;;^UTILITY(U,$J,358.3,18770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18770,1,3,0)
 ;;=3^Opioid Intox w/o Perceptual Dists w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,18770,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,18770,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,18771,0)
 ;;=F11.14^^91^961^5
 ;;^UTILITY(U,$J,358.3,18771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18771,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,18771,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,18771,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,18772,0)
 ;;=F11.182^^91^961^11
 ;;^UTILITY(U,$J,358.3,18772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18772,1,3,0)
 ;;=3^Opioid Induced Sleep D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,18772,1,4,0)
 ;;=4^F11.182
 ;;^UTILITY(U,$J,358.3,18772,2)
 ;;=^5003124
 ;;^UTILITY(U,$J,358.3,18773,0)
 ;;=F11.20^^91^961^28
 ;;^UTILITY(U,$J,358.3,18773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18773,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev,Uncomp
 ;;^UTILITY(U,$J,358.3,18773,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,18773,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,18774,0)
 ;;=F11.23^^91^961^26
 ;;^UTILITY(U,$J,358.3,18774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18774,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev w/ Withdrawal
 ;;^UTILITY(U,$J,358.3,18774,1,4,0)
 ;;=4^F11.23
 ;;^UTILITY(U,$J,358.3,18774,2)
 ;;=^5003133
 ;;^UTILITY(U,$J,358.3,18775,0)
 ;;=F11.24^^91^961^6
 ;;^UTILITY(U,$J,358.3,18775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18775,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,18775,1,4,0)
 ;;=4^F11.24
 ;;^UTILITY(U,$J,358.3,18775,2)
 ;;=^5003134
